Back to Search Start Over

MACS: Rapid Aqueous Clearing System for 3D Mapping of Intact Organs

Authors :
Jingtan Zhu
Tingting Yu
Yusha Li
Jianyi Xu
Yisong Qi
Yingtao Yao
Yilin Ma
Peng Wan
Zhilong Chen
Xiangning Li
Hui Gong
Qingming Luo
Dan Zhu
Source :
Advanced Science, Vol 7, Iss 8, Pp n/a-n/a (2020)
Publication Year :
2020
Publisher :
Wiley, 2020.

Abstract

Abstract Tissue optical clearing techniques have provided important tools for large‐volume imaging. Aqueous‐based clearing methods are known for good fluorescence preservation and scalable size maintenance, but are limited by long incubation time, insufficient clearing performance, or requirements for specialized devices. Additionally, few clearing methods are compatible with widely used lipophilic dyes while maintaining high clearing performance. Here, to address these issues, m‐xylylenediamine (MXDA) is firstly introduced into tissue clearing and used to develop a rapid, highly efficient aqueous clearing method with robust lipophilic dyes compatibility, termed MXDA‐based Aqueous Clearing System (MACS). MACS can render whole adult brains highly transparent within 2.5 days and is also applicable for other intact organs. Meanwhile, MACS possesses ideal compatibility with multiple probes, especially for lipophilic dyes. MACS achieves 3D imaging of the intact neural structures labeled by various techniques. Combining MACS with DiI labeling, MACS allows reconstruction of the detailed vascular structures of various organs and generates 3D pathology of glomeruli tufts in healthy and diabetic kidneys. Therefore, MACS provides a useful method for 3D mapping of intact tissues and is expected to facilitate morphological, physiological, and pathological studies of various organs.

Details

Language :
English
ISSN :
21983844
Volume :
7
Issue :
8
Database :
Directory of Open Access Journals
Journal :
Advanced Science
Publication Type :
Academic Journal
Accession number :
edsdoj.200110d9b6454741bede7c9445479231
Document Type :
article
Full Text :
https://doi.org/10.1002/advs.201903185